
NASDAQ:VYNT • US92942V2088
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VYANT BIO INC (VYNT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-02-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-08 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-06 | HC Wainwright & Co. | Initiate | Buy |
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.75M -21.34% | 1.148M -80.03% | 666K -41.99% | -100.00% | ||
| EBITDA YoY % growth | -4.81M -129.05% | -12.846M -167.07% | -15.39M -19.80% | -16.422M -6.71% | N/A | |
| EBIT YoY % growth | -5.44M -100.74% | -13.396M -146.25% | -15.912M -18.78% | -15.963M -0.32% | -16.779M -5.11% | |
| Operating Margin | -94.61% | -1,166.90% | -2,389.19% | N/A | N/A | |
| EPS YoY % growth | N/A -13.34% | N/A 87.80% | -3.91 -8.01% | -2.43 37.93% | -2.23 7.98% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
7 analysts have analysed VYNT and the average price target is 5.1 USD. This implies a price increase of 1861.54% is expected in the next year compared to the current price of 0.26.
VYANT BIO INC (VYNT) will report earnings on 2023-08-14.
The number of analysts covering VYANT BIO INC (VYNT) is 7.